Evaluation of antimicrobial activity of probiotic bacteria against Salmonella enterica subsp. enterica serovar typhimurium 1344 in a common medium under different environmental conditions

Research in Microbiology

Volumn 161, Issue 8, 2010, Pages 673-680

  Marianelli, Cinzia ^a   Cifani, Noemi ^a   Pasquali, Paolo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID; OXYGEN; PROBIOTIC AGENT;

ACIDITY; ANAEROBIC GROWTH; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS; BACILLUS CLAUSII; BACTERIAL GROWTH; BACTERIUM CULTURE; BIOLOGICAL MODEL; BRAIN HEART INFUSION BROTH; CONTROLLED STUDY; CULTURE MEDIUM; ENVIRONMENTAL FACTOR; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PH; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SEROTYPE; SMALL INTESTINE;

ANAEROBIOSIS; ANTIBIOSIS; BACILLUS; BACTERIOCINS; CULTURE MEDIA; HYDROGEN-ION CONCENTRATION; INTESTINAL MUCOSA; INTESTINE, SMALL; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; OXIDATIVE STRESS; PROBIOTICS; SALMONELLA TYPHIMURIUM;

LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 77957273563     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2010.06.007     Document Type: Article

References (42)

1. Abee T., Krockel L., Hill C. Bacteriocins: modes of action and potentials in food preservation and control of food poisoning. Int. J. Food Microbiol. 1995, 28:169-185.
2. Alakomi H.L., Skyttä E., Saarela M., Mattila-Sandholm T., Latva-Kala K., Helander I.M. Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl. Environ. Microbiol. 2000, 66:2001-2005.
3. Annuk H., Shchepetova J., Kullisaar T., Songisepp E., Zilmer M., Mikelsaar M. Characterization of intestinal lactobacilli as putative probiotic candidates. J. Appl. Microbiol. 2003, 94:403-412.
4. Arvola T., Laiho K., Torkkeli S., Mykkänen H., Salminen S., Maunula L., Isolauri E. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999, 104:e64.
5. Axelsson L.L.C., Chung W., Dobrogosz J., Lindgren S.E. Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri. Microbiol. Ecol. Health Dis. 1989, 2:131-136.
6. Berni Canani R., Cirillo P., Terrin G., Cesarano L., Spagnuolo M.I., De Vincenzo A., Albano F., Passariello A., De Marco G., Manguso F., Guarino A. Probiotics for treatment of acute diarrhea in children: randomised clinical trial of five different preparations. BMJ 2007, 335:340.
7. Cenci G., Trotta F., Caldini G. Tolerance to challenges miming gastrointestinal transit by spores and vegetative cells of Bacillus clausii. J. Appl. Microbiol. 2006, 101:1208-1215.
8. Cenci G., Caldini G., Trotta F., Bosi P. In vitro inhibitory activity of probiotic spore-forming bacilli against genotoxins. Lett. Appl. Microbiol. 2008, 46:331-337.
9. Cinquin C., Le Blay G., Fliss I., Lacroix C. Immobilization of infant fecal microbiota and utilization in an in vitro colonic fermentation model. Microb. Ecol. 2004, 48:128-138.
10. Cinquin C., Le Blay G., Fliss I., Lacroix C. New three-stage in vitro model for infant colonic fermentation with immobilized fecal microbiota. FEMS Microbiol. Ecol. 2006, 57:324-336.
11. De Keersmaecker S.C., Verhoeven T.L., Desair J., Marchal K., Vanderleyden J., Nagy I. Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid. FEMS Microbiol. Lett. 2006, 259:89-96.
12. De Man J.C., Rogosa M., Sharpe M.E. A medium for the cultivation of Lactobacilli. J. Appl. Bact. 1960, 23:130-135.
13. Duc L.H., Hong H.A., Barbosa T.M., Henriques A.O., Cutting S.M. Characterization of Bacillus probiotics available for human use. Appl. Environ. Microbiol. 2004, 70:2161-2171.
14. Faille C., Membre J.M., Kubaczka M., Gavini F. Altered ability of Bacillus cereus spores to grow under unfavourable conditions (presence of nisin, low temperature, acidic pH, presence of NaCl) following heat treatment during sporulation. J. Food Prot. 2002, 65:1930-1936.
15. Fayol-Messaoudi D., Berger C.N., Coconnier-Polter M.H., Liévin-Le Moal V., Servin A.L. pH-, lactic acid-, and non-lactic acid-dependent activities of probiotic lactobacilli against Salmonella enterica Serovar Typhimurium. Appl. Environ. Microbiol. 2005, 71:6008-6013.
16. Food and Agriculture Organization of the United Nations and World Health Organization, 2002. Guidelines for the evaluation of probiotics in food. Food and Agriculture Organization of the United Nations and World Health Organization Working Group Report. (Online).
17. Gunn J.S. Mechanisms of bacterial resistance and response to bile. Microbes Infect. 2000, 2:907-913.
18. Helander I.M., von Wright A., Mattila-Sandholm T.M. Potential of lactic acid bacteria and novel antimicrobials against Gram-negative bacteria. Trends Food Sci. Tech. 1997, 8:146-150.
19. Hong H.A., Duc L.H., Cutting S.M. The use of bacterial spore formers as probiotics. FEMS Microbiol. Rev. 2005, 29:813-835.
20. Howden C.W., Hunt R.H. Relationship between gastric secretion and infection. Gut 1987, 28:96-107.
21. Hütt P., Shchepetova J., Loivukene K., Kullisaar T., Mikelsaar M. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. J. Appl. Microbiol. 2006, 100:1324-1332.
22. Jacobsen C.N., Rosenfeldt Nielsen V., Hayford A.E., Møller P.L., Michaelsen K.F., Paerregaard A., Sandström B., Tvede M., Jakobsen M. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl. Environ. Microbiol. 1999, 65:4949-4956.
23. Kaur I.P., Chopra K., Saini A. Probiotics: potential pharmaceutical applications. Eur. J. Pharm. Sci. 2002, 15:1-9.
24. Le Blay G., Rytka J., Zihler A., Lacroix C. New in vitro colonic fermentation model for Salmonella infection in the child gut. FEMS Microbiol. Ecol. 2009, 67:198-207.
25. Lima E.T., Andreatti Filho R.L., Okamoto A.S., Noujaim J.C., Barros M.R., Crocci A.J. Evaluation in vitro of the antagonistic substances produced by Lactobacillus spp. isolated from chickens. Can. J. Vet. Res. 2007, 71:103-107.
26. Macfarlane G.T., Macfarlane S., Gibson G.R. Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microb. Ecol. 1998, 35:180-187.
27. Magnusson J., Ström K., Roos S., Sjögren J., Schnürer J. Broad and complex antifungal activity among environmental isolates of lactic acid bacteria. FEMS Microbiol. Lett. 2003, 219:129-135.
28. Makras L., Triantafyllou V., Fayol-Messaoudi D., Adriany T., Zoumpopoulou G., Tsakalidou E., Servin A., De Vuyst L. Kinetic analysis of the antibacterial activity of probiotic lactobacilli towards Salmonella enterica serovar Typhimurium reveals a role for lactic acid and other inhibitory compounds. Res. Microbiol. 2006, 157:241-247.
29. Mazza P. The use of Bacillus subtilis as an antidiarrheal microorganism. Boll. Chim. Farmaceutico 1994, 133:3-18.
30. Mazza P., Zani F., Martelli P. Studies on the antibiotic resistance of Bacillus subtilis strains used in oral bacteriotherapy. Boll. Chim. Farmaceutico 1992, 131:401-408.
31. McFarland L.V., Elmer G.W. Pharmaceutical probiotics for the treatment of anaerobic and other infections. Anaerobe 1997, 3:73-78.
32. Nista E.C., Candelli M., Cremonini F., Cazzato I.A., Zocco M.A., Franceschi F., Cammarota G., Gasbarrini G., Gasbarrini A. Bacillus clausii therapy to reduce side-effects of anti- Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment. Pharmacol. Ther. 2004, 20:1181-1188.
33. Ouwehand A.C. Antimicrobial Components from Lactic Acid Bacteria 1998, 139-159. Dekker, New York. S. Salminen, A. von Wright (Eds.).
34. Reid G., Jass J., Sebulsky M.T., McCormick J.K. Potential uses of probiotics in clinical practice. Clin. Microbiol. Rev. 2003, 16:658-672.
35. Sanders M.E., Morelli L., Tompkins T.A. Sporeformers as human probiotics: Bacillus, Sporalactobacillus, and Brevibacillus. Comp. Rev. Food Sci. Food Safe 2003, 2:101-110.
36. Servin A.L. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol. Rev. 2004, 28:405-440.
37. Spinosa M.R., Braccini T., Ricca E., De Felice M., Morelli L., Pozzi G., Oggioni M.R. On the fate of ingested Bacillus spores. Res. Microbiol. 2000, 151:361-368.
38. Talarico T.L., Casas I.A., Chung T.C., Dobrogosz W.J. Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrob. Agents Chemother. 1988, 32:1854-1858.
39. Talarico T.L., Dobrogosz W.J. Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri. Antimicrob. Agents Chemother. 1989, 33:674-679.
40. Threlfall E.J. Antimicrobial drug resistance in Salmonella problems and perspectives in food- and water-borne infections. FEMS Microbiol. Rev. 2002, 26:141-148.
41. Valerio F., Lavermicocca P., Pascale M., Visconti A. Production of phenyllactic acid by lactic acid bacteria: an approach to the selection of strains contributing to food quality and preservation. FEMS Microbiol. Lett. 2004, 233:289-295.
42. Vandenbergh P.A. Lactic acid bacteria, their metabolic products and interference with micorbial growth. FEMS Microbiol. Rev. 1993, 12:221-238.